Overview of Surgam

Property	Description
Active ingredient	Tiaprofenic Acid
Form	Tablet, capsule, suppository
Pharmacological class	Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common use	Symptomatic relief of pain and inflammation
Origin	Synthetic, propionic acid derivative

Surgam: Defining its Nature and Pharmaceutical Class

Surgam is a pharmaceutical product containing the active substance Tiaprofenic Acid. It is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), a class known for its ability to manage pain and inflammation without the use of corticosteroids. Tiaprofenic Acid is a synthetic compound that is chemically identified as a propionic acid derivative, placing it within a well-established family of analgesic and anti-inflammatory medications. Surgam is typically authorized as a prescription-only medicine, distinguishing its specific pharmacological profile from lower-strength, over-the-counter NSAIDs.

General Purpose and Mechanism Summary

The fundamental function of Tiaprofenic Acid is to manage symptoms by intervening in the body’s inflammatory cascade. The drug's mechanism of action involves the inhibition of prostaglandin synthesis, which limits the production of key chemical mediators responsible for signaling pain and initiating localized swelling. Pharmacological studies support the efficacy of this mechanism, recognizing Tiaprofenic Acid for its robust anti-inflammatory effects. This means the medication provides a method for directly mitigating both the swelling and the discomfort associated with inflammatory conditions.

Presentation and Availability

The active substance, Tiaprofenic Acid, is supplied in several common dosage forms for systemic administration. This primarily includes oral tablets and capsules. The drug may also be formulated as a suppository for rectal administration, offering an alternative route when oral intake is unsuitable. These variations ensure that the active component can be effectively delivered into the bloodstream to achieve its systemic therapeutic concentration against pain and inflammation.

Regulatory References

NIH RxNav Tiaprofenic Acid

What side effects are possible with Surgam?

Possible Side Effects and Safety Information

Official regulatory documentation classifies the possible adverse reactions of Tiaprofenic Acid (Surgam) based on the affected system-organ class and frequency.

Serious Adverse Reactions and High-Level Risks The medicine is associated with an increased, potentially fatal risk of serious cardiovascular thrombotic events, including heart attack and stroke. This risk is considered more likely with long-term use. Separately, serious and sometimes fatal gastrointestinal adverse events—such as peptic ulceration, perforation, and bleeding—can occur at any time during the course of treatment. Rare but severe dermatological reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are also documented.

Commonly Observed Effects Adverse reactions that are frequently cited in regulatory safety data often involve the Gastrointestinal System, and may include dyspepsia, nausea, abdominal pain, heartburn, and flatulence. Effects on the Nervous System such as headache, dizziness, and drowsiness are also commonly reported, alongside fluid retention (oedema) and dermatological effects like rash and photosensitivity.

Population-Specific Constraints Safety documentation highlights heightened risks for older adults, who are more prone to serious complications, particularly GI bleeding and cardiovascular or renal issues. The medicine is contraindicated in the final trimester of pregnancy due to potential harm to the fetus and is also contraindicated in patients with active or a history of gastroduodenal ulceration or severe hepatic or renal insufficiency. Specific laboratory monitoring, such as blood counts and liver function tests, may be required during extended therapy.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Tiaprofenic Acid (Surgam) overdose is defined by specific signs and mandated emergency actions. Documented manifestations primarily involve the gastrointestinal and central nervous systems, consistent with the non-steroidal anti-inflammatory drug (NSAID) class.

Documented Manifestations

Overdose presentations, as stated in regulatory labeling, commonly include gastrointestinal distress such as nausea, vomiting, and abdominal pain, along with central nervous system effects like drowsiness and dizziness. More severe or life-threatening outcomes reported in regulatory documents are acute renal failure, metabolic acidosis, convulsions, and circulatory collapse. Gastrointestinal complications, including haemorrhage and ulceration, are also formally documented as overdose risks. The risk of severe outcomes is noted to be greater in older patients and those with pre-existing renal impairment.

Required Emergency Actions

For any suspected overdose of Tiaprofenic Acid, government labeling explicitly mandates that patients seek immediate medical attention. Emergency services must be contacted if severe symptoms, such as passing out or trouble breathing, are observed. Management is confined to symptomatic and supportive treatment, as regulatory documents state that no specific antidote is known for this overdose. Hospital monitoring, including laboratory checks of renal function, may be required.

Therapeutic Uses of Surgam

What Surgam Treats: Main Uses and Benefits

Tiaprofenic Acid is commonly used in areas where short-term symptom management is appropriate, particularly for symptoms related to inflammatory or irritative states. It is generally applied across conditions presenting with chronic inflammatory and degenerative joint disease manifestations. The medication is utilized in addressing symptom clusters that may become intense or disruptive, such as those associated with Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis, acute gout, and pain from soft-tissue injuries.

It is considered relevant in clinical settings that involve acute or unstable symptom patterns. It is also considered relevant in contexts involving heightened systemic burden, such as managing symptoms of primary dysmenorrhea. The supportive relief may contribute to improved comfort during periods of heightened symptoms and may assist with maintaining functional stability for patients. It is used for managing symptoms of increased neurological or muscular activity in long-term arthropathies, including joint pain, tenderness, and morning stiffness.

Quick Fact: Support for Symptoms of Joint Pain and Stiffness

Surgam is generally applicable within clinical settings that involve acute or unstable symptom patterns, which interfere with daily functioning, and supports patients during difficult episodes by easing distress.

Regulatory References

Province of British Columbia PharmaCare criteria

Eligibility and Restrictions for Use

The official regulatory documents define the eligible population for Surgam (Tiaprofenic Acid) and strictly list groups for whom use is prohibited (contraindicated).

Who Must Not Use Surgam (Contraindications)

Use is absolutely prohibited for patients with a known hypersensitivity to Tiaprofenic Acid, aspirin, or any other Non-Steroidal Anti-Inflammatory Drug (NSAID). It must not be used by individuals with active gastrointestinal ulceration, a history of recurrent ulceration, or severe hepatic or renal insufficiency. Use is also prohibited in the third trimester of pregnancy, during breastfeeding, and in the setting of coronary artery bypass graft (CABG) surgery. A specific contraindication exists for patients with active cystitis or recurrent urinary tract disorders, and it must be stopped immediately if urinary symptoms develop.

Population and Age Restrictions

The medicine is established for use in the adult population (ge 18 years). It is not recommended for children and adolescents under 18 as safety and efficacy have not been established in this age group. Older adults (ge 65 years) must use the medicine with care due to the documented increased risk of serious events. Use during the first and second trimesters of pregnancy is generally not recommended and requires medical assessment.

What should I know about interactions with other medicines?

Interactions with other medicines and products — official regulatory information for Tiaprofenic Acid

Tiaprofenic Acid is officially documented to interact with several medicinal products and substance classes, leading to regulatory-defined constraints on co-administration.

Interaction Scope	Officially Documented Information
Medicinal product categories	NSAIDs, Salicylates, Oral Anticoagulants, Corticosteroids, Diuretics, Anti-hypertensives, Oral Hypoglycaemic Agents (Sulfonylurea drugs), Aminoglycosides, Quinolone Antibiotics
Specific interacting medicines	Mifepristone, Methotrexate, Lithium, Warfarin
Timing-based rules	Avoidance is mandated for 8–12 days after Mifepristone administration
Population-specific notes	Contraindicated in severe renal or hepatic insufficiency. Elderly patients are at greater risk for renal adverse reactions

Interaction Classifications (High-Level)

Classification	Official Regulatory Constraint
Interaction severity	Contraindicated (e.g., with other NSAIDs); Requires Caution/Monitoring (e.g., with Lithium, Anticoagulants); Avoid (e.g., high-dose Methotrexate)
Interaction-context constraints	Alcohol use may increase the risk of stomach bleeding. Interaction with Antacids results in reduced absorption of Tiaprofenic Acid

Official Interaction Statements:

Co-administration with other NSAIDs and high-dose salicylates is officially contraindicated due to increased risk of gastrointestinal toxicity and hemorrhage.
Combining with oral anticoagulants carries a documented increased risk of bleeding and hemorrhage.
The label indicates that co-administration with lithium, methotrexate, or aminoglycosides can result in decreased elimination and consequent increased plasma concentrations of those drugs.
Interactions with anti-hypertensives and diuretics are documented to reduce their efficacy and introduce an increased risk of renal impairment.

Connection to the overall interaction profile

Regulatory documents define this profile by detailing the additive risk for bleeding when combined with agents affecting coagulation or the GI lining (pharmacodynamic interaction), and the risk of elevated exposure of co-administered agents (pharmacokinetic interaction) resulting from effects on drug clearance. These official statements structure mandatory constraints and prohibited combinations necessary for regulatory compliance.

Mechanism of Action

Enzyme Inhibition and Anti-Inflammatory Modulation

The primary action of the molecule, Tiaprofenic Acid, is the competitive inhibition of the Cyclooxygenase (COX) enzyme system, targeting both the constitutive COX-1 and inducible COX-2 isoforms. This interaction interrupts the Arachidonic Acid Cascade, leading to a sharp reduction in the synthesis of key inflammatory mediators, most notably Prostaglandin E2 (PGE2) . This dampening of the PGE2-driven pathway reduces localized tissue edema and modulates the inflammatory physiological cascade.

Pathway Cascades and Nociception Control

The systemic reduction of PGE2 causes a consequential attenuation of peripheral nociceptive sensitization; it raises the firing threshold of pain-transmitting neurons, which contributes to the molecular elevation of the pain threshold. Furthermore, the molecule's action on PGE2 within the hypothalamic central thermoregulatory center allows the body to reset its temperature set point, leading to a downstream antipyretic physiological response.

Non-Prostaglandin Mechanisms and Limitations

In addition to COX inhibition, the mechanism involves the modulation of joint cartilage matrix metabolism through the inhibition of proteoglycan degradation, a non-prostaglandin-mediated effect. Mechanistically, the drug's efficacy is constrained where the physiological response is dominated by mediators outside the COX pathway, such as specific leukotrienes or certain cytokines, where the inhibitory action is mechanistically constrained.

Dosage and Administration Information

Surgam (Tiaprofenic Acid) is administered by the oral route, commonly as tablets or sustained-release capsules, or by the rectal route via suppository. The standard total daily dose for adults is 600 mg. This amount is typically taken in divided doses, such as 300 mg twice daily or 200 mg three times daily. A sustained-release formulation of 600 mg allows the total daily dose to be taken once daily.

The administration is subject to specific procedural rules regarding intake conditions. Oral doses must be swallowed whole with a full glass of water, and it is specified that the medication should be taken with or immediately after food to aid proper use. After taking an oral dose, the individual should remain upright for at least 10 minutes. The medication should be utilized at the lowest effective dose for the shortest duration possible.

Dosing requires specific adjustments for certain populations; for older adults, the lowest possible dose is indicated. In cases of impaired renal or hepatic function, a dose reduction to 400 mg per day (200 mg twice daily) is suggested, while use in children is not recommended due to insufficient data. If a dose is missed, it is specified to skip the missed dose entirely and resume the regular schedule, without taking a double amount.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tiaprofenic Acid (Surgam)

Evidence for Use in Osteoarthritis

Research examined Tiaprofenic Acid in the context of conditions marked by functional limitations and joint discomfort, such as Osteoarthritis. The research base includes short-term Randomized Controlled Trials (RCTs) and analyses that pool data from several trials. Studies explored the changes measured during the study period, with short-term trials describing measurements when compared to placebo or active control groups. Researchers primarily measured scores for pain intensity and outcomes reflecting daily functioning.

Evidence for Use in Rheumatoid Arthritis

Tiaprofenic Acid was evaluated in conditions characterized by fluctuating or episodic manifestations, such as active Rheumatoid Arthritis (RA). The studies monitored outcomes linked to phases of heightened symptom activity, including measures of joint swelling and tenderness, as well as the duration of morning stiffness. Findings indicate patterns of symptomatic change over these periods, and studies report how symptoms evolved in the observed populations with active RA.

Long-Term Studies and Limitations

Research has explored the use of the compound over defined time intervals, but evidence is limited regarding whether it influences the long-term course of degenerative joint disease or provides insight into preventing structural joint damage. The research base is primarily focused on symptom relief and not on long-term structural outcomes. Follow-up durations were limited in many key studies, and comparative evidence is lacking against the full range of modern treatment options. Data for certain groups, such as children, remain insufficient, and overall certainty remains low for long-term effects.

Frequently Asked Questions (FAQ)

Common questions about Surgam (FAQ)

Q: Does Surgam help with types of pain that aren't related to inflammation?

Official documents classify Surgam as a medicine with analgesic (pain-relieving) and anti-inflammatory properties. This means that while its primary function is to reduce inflammation, its mechanism of action is described as involving the dampening of pain signals and a modulation of the pain threshold.

Q: What are people generally using Surgam for, based on patient forum discussions?

According to the official product information, the medicine is approved for the symptomatic relief of signs and symptoms of inflammatory conditions. These specifically include chronic conditions such as rheumatoid arthritis and osteoarthritis.

Q: What should I know about potential interactions between Surgam and common supplements?

Regulatory documents define interactions between Surgam and many classes of prescription medicines (e.g., anticoagulants, diuretics). Official warnings are also provided for substances like alcohol and antacids. Interactions with common dietary supplements are generally not documented in the main regulatory materials.

Q: Are there any studies comparing Surgam's profile in different patient groups?

Studies have examined how the medicine is processed in the body, known as pharmacokinetics, across different patient groups. For example, specific pharmacokinetic studies have been conducted in older adults and in patients with rheumatoid arthritis to ensure proper understanding of absorption and clearance.

Q: Does taking Surgam with food make a difference in how it is absorbed?

Taking Surgam with food is officially advised to aid proper use. Regulatory data indicates that food can affect how quickly the medicine is absorbed, increasing the time required to reach the highest concentration in the blood.

Q: Are there any specific lifestyle changes that are mentioned alongside taking Surgam?

Official instructions specify that the medication should be taken with or immediately after food. The product information also states that remaining upright for at least 10 minutes is a procedural rule after taking an oral dose.

Q: Why is Surgam sometimes prescribed for conditions outside of joint pain?

While commonly associated with arthritis, official documents indicate the medicine is also authorized for other uses. This includes the relief of pain and inflammation linked to musculoskeletal disorders, various soft-tissue injuries, and acute pain from different origins.

Q: How quickly does Surgam start to work after the first dose?

According to pharmacokinetic studies, the highest level of the medicine in the blood is typically reached within 30 minutes to 1.5 hours after an oral dose.

Q: How long does the effect of a single dose of Surgam typically last?

Official data indicates that the medicine's plasma elimination half-life (the time it takes for half of the drug to be removed from the body) is around 1.5 to 2.5 hours following a single dose.

Q: Is it normal to feel no effect from Surgam for the first few days?

While some pain relief may be noted quickly, the drug is used to manage inflammatory conditions over time. Regulatory information indicates that the amount of medicine in the body stabilizes after approximately one day of continuous treatment.

Q: Can Surgam be taken at the same time as cold or flu medications?

The use of Surgam is officially contraindicated (prohibited) with other non-steroidal anti-inflammatory drugs (NSAIDs). Since many over-the-counter cold and flu medications contain NSAIDs, therefore, checking the ingredients of any co-administered medicine is required due to the prohibition.

Q: What kind of research has been done on Surgam for muscle injuries?

Beyond its use in arthritis, official product documents and research overviews describe Tiaprofenic Acid's role in addressing pain and inflammation. The medicine is advocated for use in various musculoskeletal disorders and soft-tissue injuries.

Q: Does the name 'Surgam' refer to a specific ingredient?

The name Surgam is a brand name used to market the active pharmaceutical ingredient. The active ingredient itself is Tiaprofenic Acid, which is the molecule responsible for the medicine's effects.

Q: Is it okay to stop taking Surgam suddenly, or does the official information mention a gradual approach?

Official sources do not provide a specific cessation protocol or require a gradual withdrawal. However, regulatory documents describe that stopping the medicine may lead to a loss of symptom control for the condition being treated.

Q: Can people who have a history of asthma use Surgam?

The official product information specifies that the medicine is contraindicated (use is prohibited) in individuals who have had acute asthmatic attacks precipitated by aspirin or any other non-steroidal anti-inflammatory drug (NSAID).

Q: What are the official guidelines regarding Surgam use and driving or operating machinery?

Due to reported side effects on the nervous system, such as dizziness and drowsiness, official warnings exist. The occurrence of these effects requires caution when engaging in activities like driving or operating machinery.

Q: What is the usual recommended length of treatment with Surgam according to official sources?

Regulatory documents stress that the medicine must be used for the shortest duration possible to manage symptoms effectively. The official requirement is that the medication should not be taken for longer than the period specified by the prescribing physician.

Q: Can Surgam be used to treat headaches or migraines?

Official documentation indicates that the medicine has been prescribed to treat various types of pain. These uses include the management of migraine headaches and other forms of acute pain originating from different sources.

Q: What research supports the use of Surgam for menstrual pain?

Regulatory and clinical sources document the use of Tiaprofenic Acid for pain relief in gynecological contexts. The medicine may be prescribed for the symptomatic management of menstrual cramps and related pain.

Q: Are there any known differences in how generic versions of Surgam work?

According to general regulatory standards, generic versions of a medicine must contain the same active ingredient (Tiaprofenic Acid) as the brand-name product. Generics must also be proven to work the same way in the body and be absorbed in the same amount of time.

How should Surgam be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory information for Surgam (tiaprofenic acid) defines specific requirements for temperature control, protection, handling, and final disposal.

Storage Scope	Requirement
Temperature Control	Store at room temperature (below 25 C). Do not refrigerate or freeze.
Handling & Protection	Protect the medicine from both light and moisture. Keep the product in its original packaging.
Security	Store the medicine securely, keeping it out of the reach and sight of children and pets.
Disposal Instructions	Do not flush expired or unused Surgam down the toilet or pour it into a drain. Consult a pharmacist or local waste disposal service for guidance on official drug take-back or hazardous waste disposal programs.

Surgam